Rosacea Treatment Options Reviewed by Leading Dermatologists

Rosacea is a chronic skin affecting 16 million Americans and often worsens without treatment. Jeffrey Poole, M.D., a dermatologist in private practice in Metairie, Louisiana has published his clinical opinion regarding rosacea treatment  to help increase awareness of the need for early diagnosis and the availability of treatment options.

Rosacea, a lifelong and potentially progressive disorder, can be broken down into three main types. Most of the medicines we use for rosacea work on papulopustular rosacea”, said Jeffrey Poole, M.D.   “These include topicals, such as metronidazole and azelaic acid, and oral medicines such as doxcycycline (Oracea) and minocycline. They are very effective in decreasing the red pimples and bumps. Long-term treatment for control is the rule, and flares tend to recur as medicines are weaned."

Rosacea is a chronic skin condition that causes redness and swelling of the face that can also affect other region.  Those afflicted with rosacea may first notice a tendency to flush or blush easily. The condition progresses to persistent redness, pimples, and visible, threadlike blood vessels in the center of the face. Doctors will recommend treatments based on the type of rosacea, its severity, the patient’s skin type and other variables.

Dr. Poole received his undergraduate education from the University of Virginia. He earned his medical degree from Tulane University School of Medicine, while on a full scholarship from the United States Air Force. In addition to his private practice, Dr. Poole is also an Assistant Clinical Professor of Dermatology at both the LSU and Tulane Schools of Medicine, acting as their Pediatric and Adolescent specialist, and remains a Board Certified Pediatrician.

The clinical perspective of Dr. Poole and other leading dermatologists are made available through Vivacare’s “From Your Doctor” patient education service that publishes the expert opinion of over 3,000 dermatologists with the goal of providing patients with practical health information from the source they trust most.